Production of Soluble ScFvs with C-Terminal-Free Thiol for Site-Specific Conjugation or Stable Dimeric ScFvs on Demand-Reference-Cited by-同舟云学术

Production of Soluble ScFvs with C-Terminal-Free Thiol for Site-Specific Conjugation or Stable Dimeric ScFvs on Demand

Published:2003-12-31 Issue:1 Volume:15 Page:16-26
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Albrecht Huguette¹,Burke Patricia A.¹,Natarajan Arutselvan¹,Xiong Cheng-Yi¹,Kalicinsky Mark¹,DeNardo Gerald L.¹,DeNardo Sally J.¹

Affiliation:

1. Radiodiagnosis and Therapy, Molecular Cancer Institute, University of California Davis Medical Center, Sacramento, California 95816

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc030018%2B

Reference56 articles.

1. Treatment of a Patient with b Cell Lymphoma by 1-131 Lym-1 Monoclonal Antibodies

2. Juweid, M. E., Stadtmauer, E., Hajjar, G., Sharkey, R. M., Suleiman, S., Luger, S., Swayne, L. C., Alavi, A., Goldenberg, D. M. (1999) Pharmacokinetics, dosimetry and initial therapeutic results with131I- and111In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody (MAb) in patients with relapsed/refractory non-Hodgkin's lymphoma (NHL).Clin. Cancer Res.5, 3292s−3303s.

3. Phase I/II Trial of IDEC-Y2B8 Radioimmunotherapy for Treatment of Relapsed or Refractory CD20+ B-Cell Non-Hodgkin's Lymphoma

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody mimetics: The next generation antibody engineering, a retrospective and prospective analysis;Biotechnology Journal;2023-12-21

2. Development of Antibody-Drug Conjugates: Future Perspective Towards Solid Tumor Treatment;Anti-Cancer Agents in Medicinal Chemistry;2023-04

3. Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells;International Journal of Molecular Sciences;2023-01-08

4. Poly (beta‐amino ester) as an in vivo nanocarrier for therapeutic nucleic acids;Biotechnology and Bioengineering;2022-11-12

5. Selective Delivery of Clinically Approved Tubulin Binding Agents through Covalent Conjugation to an Active Targeting Moiety;Current Medicinal Chemistry;2022-09